Research location

New Albany

Indiana, United States

Published trials97

Site observations98

Linked trials published97

Page2 / 2

Research activity in New Albany

Indiana, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 97 trials and 98 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in New Albany

97 linked trials · page 2 of 2

QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung CancerNCT00807612 · 2009-01-01 · 2 site observations

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCNCT00806819 · 2008-12-01 · 1 site observation

A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung CancerNCT00762034 · 2008-12-01 · 1 site observation

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With AsthmaNCT00809757 · 2008-12-01 · 1 site observation

Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast CancerNCT00667251 · 2008-10-07 · 1 site observation

Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerNCT00686959 · 2008-09-01 · 1 site observation

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.NCT00717457 · 2008-07-01 · 1 site observation

Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular EdemaNCT00701181 · 2008-06-01 · 1 site observation

BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabNCT00625898 · 2008-04-01 · 1 site observation

APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung CancerNCT00652340 · 2008-04-01 · 1 site observation

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy SubjectsNCT00664183 · 2008-03-01 · 1 site observation

A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00606684 · 2008-02-01 · 1 site observation

GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLNCT00576225 · 2007-09-01 · 1 site observation

Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00551733 · 2007-08-01 · 1 site observation

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or ErlotinibNCT00522145 · 2007-05-01 · 1 site observation

Laser-Ranibizumab-Triamcinolone for Diabetic Macular EdemaNCT00444600 · 2007-03-01 · 1 site observation

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyNCT00445003 · 2007-03-01 · 1 site observation

The Course of Response to Focal Photocoagulation for DMENCT00442156 · 2007-01-01 · 1 site observation

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerNCT00373256 · 2006-11-01 · 1 site observation

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 DiabetesNCT00355849 · 2006-08-01 · 1 site observation

A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)NCT00336323 · 2006-06-01 · 1 site observation

Safety and Efficacy of Inhaled Insulin in Type 1 DiabetesNCT00322257 · 2006-05-01 · 1 site observation

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00333151 · 2006-05-01 · 1 site observation

Evaluation of a New Agent for Treatment of Advanced Stage Breast CancerNCT00313248 · 2006-04-01 · 1 site observation

A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung CancerNCT00317200 · 2006-04-01 · 1 site observation

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125)NCT00297115 · 2006-03-01 · 1 site observation

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerNCT00320710 · 2006-02-01 · 1 site observation

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaNCT00277498 · 2005-12-01 · 1 site observation

Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung CancerNCT00254891 · 2005-11-01 · 1 site observation

Evaluation of Vitrectomy for Diabetic Macular EdemaNCT00709319 · 2005-07-01 · 1 site observation

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00097877 · 2005-01-01 · 1 site observation

Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung CancerNCT00216216 · 2005-01-01 · 1 site observation

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerNCT00097344 · 2004-12-01 · 1 site observation

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerNCT00112294 · 2004-12-01 · 1 site observation

A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerNCT00399789 · 2004-09-01 · 1 site observation

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerNCT00081796 · 2004-04-01 · 1 site observation

Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast CancerNCT00216021 · 2004-03-01 · 1 site observation

A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 DiabetesNCT00645268 · 2002-12-01 · 1 site observation

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerNCT00050960 · 2002-05-01 · 1 site observation

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung CancerNCT00216125 · 2002-02-01 · 1 site observation

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00054392 · 2001-09-01 · 1 site observation

Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation

Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerNCT00017459 · 2000-07-01 · 1 site observation

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous HemorrhageNCT00198510 · 1998-11-01 · 1 site observation

Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT00080340 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.